Raymond F Schinazi Selected Research

Opportunistic Infections (Opportunistic Infection)

5/2010

3'-(1,2,3-Triazol-1-yl)-3'-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond F Schinazi Research Topics

Disease

41	Infections 12/2023 - 05/2002
18	Neoplasms (Cancer) 01/2024 - 01/2004
17	COVID-19 04/2024 - 05/2020
12	HIV Infections (HIV Infection) 10/2022 - 01/2003
12	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 04/2002
11	Inflammation (Inflammations) 12/2023 - 05/2015
6	Virus Diseases (Viral Diseases) 01/2024 - 07/2014
6	Chronic Hepatitis B 07/2023 - 05/2002
5	Body Weight (Weight, Body) 12/2021 - 07/2007
5	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 07/2005
4	Hepatitis C 02/2014 - 01/2006
3	Encephalitis (Encephalitis, Rasmussen) 08/2023 - 01/2016
3	Chronic Hepatitis C 06/2021 - 07/2014
3	Viremia 01/2014 - 09/2007
2	Genomic Instability 12/2023 - 01/2020
2	Hepatitis B 07/2023 - 03/2020
2	Human Influenza (Influenza) 01/2023 - 01/2022
2	Fibrosis (Cirrhosis) 01/2021 - 10/2016
2	Zika Virus Infection 01/2020 - 01/2017
2	Neuroinflammatory Diseases 01/2020 - 09/2019
2	Gliosis 09/2019 - 01/2016
2	Rheumatoid Arthritis 09/2019 - 01/2014
2	Drug-Related Side Effects and Adverse Reactions 01/2019 - 12/2012
2	Dengue (Dengue Fever) 01/2019 - 01/2006
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 11/2017
2	Primary Myelofibrosis (Myelosclerosis) 01/2016 - 01/2014
2	Liver Diseases (Liver Disease) 07/2014 - 11/2013
2	Communicable Diseases (Infectious Diseases) 07/2014 - 12/2006
2	Prostatic Neoplasms (Prostate Cancer) 04/2010 - 01/2004
2	T-Cell Lymphoma (Lymphoma, T Cell) 06/2007 - 07/2005
2	Parasitic Diseases (Parasitic Disease) 08/2004 - 06/2003
2	Diarrhea 01/2003 - 12/2002
1	Hematologic Neoplasms (Hematological Malignancy) 05/2024
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2024
1	Mpox (monkeypox) 11/2023
1	Neurodevelopmental Disorders 09/2023
1	Arbovirus Encephalitis (Epidemic Encephalitis) 08/2023
1	Pneumonia (Pneumonitis) 01/2022

Drug/Important Bio-Agent (IBA)

29	NucleosidesIBA 12/2023 - 01/2003
27	Antiviral Agents (Antivirals)IBA 04/2024 - 01/2003
8	CytokinesIBA 01/2023 - 09/2019
8	baricitinibIBA 01/2022 - 09/2019
8	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2003
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2020
7	InterferonsIBA 12/2023 - 07/2014
7	ruxolitinibIBA 01/2022 - 01/2014
6	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 09/2007
5	triphosphoric acid (triphosphate)IBA 01/2024 - 05/2002
5	NucleotidesIBA 01/2020 - 05/2010
5	Lamivudine (Epivir)FDA Link 01/2007 - 05/2002
4	Histidine (L-Histidine)FDA Link 01/2024 - 12/2020
4	Aspartic Acid (Aspartate)FDA Link 01/2024 - 12/2020
4	VaccinesIBA 11/2023 - 01/2017
4	ProdrugsIBA 08/2023 - 01/2008
4	Ribavirin (Virazole)FDA LinkGeneric 08/2023 - 04/2004
4	remdesivirIBA 01/2022 - 10/2020
4	Janus Kinase InhibitorsIBA 01/2022 - 01/2016
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2015 - 06/2005
3	Interferon-alpha (Interferon Alfa)IBA 07/2023 - 04/2004
3	RacivirIBA 01/2022 - 05/2002
3	EnzymesIBA 10/2021 - 01/2015
3	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2021 - 02/2014
3	SofosbuvirIBA 01/2020 - 07/2014
3	Reverse Transcriptase InhibitorsIBA 11/2015 - 07/2012
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2024 - 01/2020
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 12/2023 - 01/2017
2	molnupiravirIBA 08/2023 - 09/2022
2	LigandsIBA 01/2022 - 11/2021
2	SAM Domain and HD Domain-Containing Protein 1IBA 01/2022 - 10/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 05/2020
2	Emtricitabine (Emtriva)FDA Link 01/2022 - 12/2012
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2021
2	AntigensIBA 01/2021 - 11/2013
2	ChemokinesIBA 01/2021 - 09/2020
2	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 11/2017
2	Viral RNAIBA 01/2018 - 07/2010
2	SimeprevirIBA 10/2016 - 07/2014
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2016 - 12/2013
2	ThymidineIBA 07/2012 - 05/2010
2	Stavudine (Zerit)FDA LinkGeneric 11/2011 - 03/2009
2	phytobacteriomycin (PBM)IBA 06/2007 - 07/2005
2	UridineIBA 11/2006 - 06/2005
2	Fluorouracil (Carac)FDA LinkGeneric 11/2006 - 06/2005
2	AlkaloidsIBA 08/2004 - 06/2003
1	CTPaseIBA 01/2024
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 11/2023
1	favipiravirIBA 08/2023
1	LactamsIBA 01/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	Chloroquine (Aralen)FDA LinkGeneric 12/2022
1	N(4)-hydroxycytidineIBA 09/2022
1	EstersIBA 09/2022

Therapy/Procedure

29	Therapeutics 01/2024 - 05/2002
9	Highly Active Antiretroviral Therapy (HAART) 10/2022 - 05/2002
3	Oral Administration 08/2023 - 07/2007
3	Art Therapy 01/2018 - 01/2015
2	Drug Therapy (Chemotherapy) 01/2019 - 11/2017
2	Boron Neutron Capture Therapy 09/2005 - 01/2004